Browsing PubMed İndeksli Yayınlar Koleksiyonu by Author "Zarrabi, A."
Now showing items 1-5 of 5
-
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Entezari, M.; Hashemi, D.; Taheriazam, A.; Zabolian, A.; Zabolian, A.; Fakhri, F.; Hashemi, M.; Hushmandi, K.; Ashrafizadeh, M.; Zarrabi, A.; Ertas, Y.N.; Mirzaei, S. (Elsevier, 2022)Diabetes mellitus (DM) is considered as a main challenge in both developing and developed countries, as lifestyle has changed and its management seems to be vital. Type I and type II diabetes are the main kinds and they ... -
Antineoplastic activity of biogenic silver and gold nanoparticles to combat leukemia: Beginning a new era in cancer theragnostic
Mostafavi, E.; Zarepour, A.; Barabadi, H.; Zarrabi, A.; Truong, L.B.; Medina-Cruz, D. (Elsevier B.V., 2022)The American Cancer Society estimated around 61,090 new cases of leukemia were diagnosed, and around 23,660 people died from this disease in the United States alone in 2021. Due to its burden on society, there is an unmet ... -
Mesoporous silica@chitosan@gold nanoparticles as “on/off” optical biosensor and pH-sensitive theranostic platform against cancer
Esmaeili, Y.; Khavani, M.; Bigham, A.; Sanati, A.; Bidram, E.; Zarrabi, A. (Elsevier, 2022)A cancer nanotheranostic system was fabricated based on mesoporous silica@chitosan@gold (MCM@CS@Au) nanosystem targeted by aptamer toward the MUC-1 positive tumor cells. Subsequently, curcumin as an efficient herbal ... -
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Faskhoudi, M.A.; Molaei, P.; Sadrkhanloo, M.; Orouei, S.; Hashemi, M.; Bokaie, S.; Rashidi, M.; Entezari, M.; Zarrabi, A.; Hushmandi, K.; Mirzaei, S.; Gholami, M.H. (Elsevier GmbH, 2022)The c-Myc signaling is a new emerging target in cancer therapy. Activation of c-Myc signaling leads to cancer growth and invasion in vitro and in vivo. The stability of c-Myc can also mediate drug resistance and radioresistance ... -
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Mirzaei, S.; Paskeh, M.D.A.; Saghari, Y.; Zarrabi, A.; Hamblin, M.R.; Entezari, M.; Hashemi, M.; Aref, A.R.; Hushmandi, K.; Kumar, A.P.; Rabiee, N.; Ashrafizadeh, M. (Elsevier B.V., 2022)Transforming growth factor-beta (TGF-β) is a member of a family of secreted cytokines with vital biological functions in cells. The abnormal expression of TGF-β signaling is a common finding in pathological conditions, ...
